DOCUMENT RESOURCES FOR EVERYONE
Economy & Finance Conference Call 4Q09

1. 4Q09 and 2009 Earnings Release March, 10th, 2009. 2. 4Q09 and 2009 Earnings Release Highlights For The Period Net profit of the Company increased 68.0%, when comparing…

Economy & Finance Profarma apresentação 1 q10 final

1. 1Q10 Earnings Release May, 13th, 2010. 2. 1Q10 Earnings ReleaseHighlights For The Period• Gross revenue reached R$ 766.0 million, showing a 15.8% growth when comparing…

Documents Profarma 3Q12

1. 1 2. 3Q12 Earnings Release November, 8th, 2012 2 3. 3Q12 Results | Highlights in the Period• Entry into the special and high value-added medication market on July 23,…

Health & Medicine 2 q14 final

1. August 15, 2014 2Q14 EARNINGS RELEASE 2. Highlights | Corporate 2 The only Brazil’s mixed market player that features exposure and expansion capacity in the segments…

Business Divulgação de resultados 2Q14

1. August 15, 2014 2Q14 EARNINGS RELEASE 2. Highlights | Corporate 2 Only player positioned in the Brazilian market in the segments of Distribution, Retail, and Hospital…

Economy & Finance Profarma Er Presentation 1 T08 20080506 Eng

1. 1 Earnings Release 1T08 2. Highlights For The Period2 • Growth of 26.5% in consolidated Gross Revenue when compared to the same period of the previous year, reaching…

Documents Earnings Release 2Q09 Presentation

1. 2Q09 Earnings Release Monday, August, 3rd, 2009. 2. 2Q09 Earnings Release Highlights For The Period • Net Income increased 66.2% in relation to the 2Q08, reaching R$…

Economy & Finance Profarma Apr2 T08 20080729 Eng

1. 1 Earnings Release 2Q08 2. Highlights For The Period2• A growth of 21.8% of the consolidated Gross Revenue when compared to the same period of the previous year, having…

Documents Earnings Release 2Q08 Presentation

1. 1 Earnings Release 2Q08 2. Highlights For The Period2• A growth of 21.8% of the consolidated Gross Revenue when compared to the same period of the previous…

Documents Earnings Release 1Q08 Presentation

1. 1 Earnings Release 1T08 2. Highlights For The Period2 • Growth of 26.5% in consolidated Gross Revenue when compared to the same period of the previous year,…